Tobramycin/dexamethasone
 | This article contains promotional content. (January 2010) |
 | This article needs additional citations for verification. (January 2010) |
|
| Combination of | |
|---|---|
| Tobramycin | Aminoglycoside antibiotic |
| Dexamethasone | Glucocorticoid |
| Clinical data | |
| Routes of administration | Ophthalmic |
| Legal status | |
| Legal status |
|
| Identifiers | |
| CompTox Dashboard (EPA) | |
Tobradex (tobramycin and dexamethasone ophthalmic suspension USP) is a prescription medication marketed in the United States by Alcon. The active ingredients are tobramycin 0.3% (an antibiotic) and dexamethasone 0.1% (a corticosteroid). Tobradex is a trademark of Alcon Labs. It is prescribed for a wide spectrum of bacterial eye infections. Tobradex can also be used to clear or contract styes that are also found in the eye. Tobradex is sometimes prescribed for the treatment of pink eye. Because it contains a steroid, careful use with gradual reduction of doses is required. It is strongly contraindicated with herpetic eye infections. NDC 0065-0647-08.[1]
References
- ^ [ecatalog.alcon.com/pi/TobraDexSusp_us_en.pdf Tobradex Prescribing Information]. Alcon.
 | This medical treatment–related article is a stub. You can help Wikipedia by expanding it. |